![Xiao Ni Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiao Ni Zhang
Corporate Officer/Principal en HaploX Investment Holding Ltd. .
Perfil
Xiao Ni Zhang currently works at HaploX Investment Holding Ltd., as Vice President from 2021.
Ms. Zhang received her graduate degree in 2013 from Capital Normal University.
Cargos activos de Xiao Ni Zhang
Empresas | Cargo | Inicio |
---|---|---|
HaploX Investment Holding Ltd.
![]() HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01/12/2021 |
Formación de Xiao Ni Zhang.
Capital Normal University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
HaploX Investment Holding Ltd.
![]() HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
- Bolsa de valores
- Insiders
- Xiao Ni Zhang